Christine Pampeno

Title: Christine Pampeno: Innovator in Antitumor Immunity

Introduction

Christine Pampeno is a notable inventor based in New York, NY, who has made significant contributions to the field of cancer treatment through her innovative research. With a focus on enhancing antitumor immunity, she has developed groundbreaking methods that utilize viral vectors to combat cancer.

Latest Patents

Christine Pampeno holds two patents that showcase her expertise in the field. Her latest patents include the induction and enhancement of antitumor immunity involving virus vectors expressing multiple epitopes of tumor-associated antigens and immune checkpoint inhibitors or proteins. This invention provides polynucleotides and viral vectors, such as alphavirus or Sindbis viral vectors, that encode multiple epitopes of at least one tumor-associated antigen. Each epitope is separated by a processing or enzyme cleavage site, allowing for effective treatment methods for subjects with cancer. Additionally, her work involves the use of Sindbis virus vectors that express immune checkpoint proteins, which can significantly reduce tumor growth and increase survivability in treated subjects.

Career Highlights

Christine Pampeno is affiliated with New York University, where she continues her research and development in the field of immunotherapy. Her work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.

Collaborations

Some of her notable coworkers include Daniel Meruelo and Alicia Hurtado Martinez, who collaborate with her on various research projects aimed at advancing cancer therapies.

Conclusion

Christine Pampeno's innovative work in antitumor immunity exemplifies the impact of research and invention in the fight against cancer. Her contributions through patents and collaboration with esteemed colleagues highlight her commitment to improving cancer treatment and patient survivability.